Norway· NO-ID_473BC38D-2E1A-4CF2-93D3-A3BEF7DF86EB
Enerzair Breezhaler
A indacaterol, glycopyrronium bromid und mometason product containing mometasone furoate + glycopyrronium bromide + indacaterol, registered in Norway by Novartis Europharm Limited (1). The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Indacaterol, glycopyrronium bromid und mometason is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL12 (indacaterol, glycopyrronium bromid und mometason), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Indacaterol, glycopyrronium bromid und mometason · ATC R03AL12
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Mometasone Furoate + Glycopyrronium Bromide + Indacaterol
- Manufacturer
- Novartis Europharm Limited (1)
- Country
- Norway (NO)
- ATC code
- R03AL12
- ATC class
- Indacaterol, Glycopyrronium bromid und Mometason
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_varenummer39826590 x 1NOK 2068.7
- no_varenummer58071330 x 1NOK 742.8
- gtin7613421043841
- gtin7613421043834
- no_merkevare_idID_473BC38D-2E1A-4CF2-93D3-A3BEF7DF86EB
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol, glycopyrronium bromid und mometason in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENERZAIR BREEZHALERNovartis Europharm Limited, Dublin
- FinlandEnerzair BreezhalerNovartis Europharm Limited
- IrelandEnerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsulesNovartis Europharm Limited
- SwedenEnerzair Breezhaler 114 mikrogram/46 mikrogram/136 mikrogram Inhalationspulver, hård kapselNovartis Europharm Limited
- United KingdomEnerzair Breezhaler 114micrograms/dose / 46micrograms/dose / 136micrograms/dose inhalation powder capsules with deviceNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Enerzair Breezhaler, Zimbus Breezhaler
- Liechtenstein · Enerzair Breezhaler, Zimbus Breezhaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9a77828-6168-40d4-9b83-186c384dfaca GET /v1/drugs/c9a77828-6168-40d4-9b83-186c384dfaca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalasjonspulver, hard kapsel",
"source": "fest",
"status": "A",
"atc_name": "Indakaterol, glykopyrroniumbromid og mometason",
"merkevare_id": "ID_473BC38D-2E1A-4CF2-93D3-A3BEF7DF86EB",
"name_form_strength": "Enerzair Breezhaler inh pulv, kaps 114 mikrog/46 mikrog/136 mikrog",
"prescription_group": "C"
}See everything about indacaterol, glycopyrronium bromid und mometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.